4559:TYO
Zeria Pharmaceutical Co Ltd
1.951,00 JPY
0,00%
(0,00) 1D
1. lis, 15:30:00 GMT+9 · JPY
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 4559...
Trž. kap.
97,78 mlr.
Prosj. kol.
162,22 tis.
Količina
0,00
Dividenda
2,51 %
Kvartalna dividenda
12 JPY
Datum nakon isplate dividende
29. ruj 2026.
P/E omjer
10,45
52-tjed. najviša
2.434 JPY
52-tjed. najniža
1.878 JPY
EPS
187 JPY
Dionice u optjecaju
50,11 mil.
Broj djelatnika
2 tis.
Trž. kap.
97,78 mlr.
Prosj. kol.
162,22 tis.
Količina
0,00
Dividenda
2,51 %
Kvartalna dividenda
12 JPY
Datum nakon isplate dividende
29. ruj 2026.
P/E omjer
10,45
52-tjed. najviša
2.434 JPY
52-tjed. najniža
1.878 JPY
EPS
187 JPY
Dionice u optjecaju
50,11 mil.
Broj djelatnika
2 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Naslovi.net
·
prije 13 sati
Wall Street: Rast za S&P 500 na kraju rujna
Naslovi.net
·
prije 1 dan
Wall Street: Dow Jones pao drugi uzastopni dan
MarketBeat
·
prije 7 minuta
Apple (NASDAQ:AAPL) SVP Jennifer Newstead Sells 2,399 Shares of Stock
Nasdaq
·
prije 23 minute
A Quarter of Companies Have No Analyst Coverage
Profil
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Zeria Pharmaceutical Co Ltd – informacije
Glavni izvršni direktorSachiaki Ibe
Zaposlenici1,75 tis.
Osnovano22. pro 1955.
Sjedište-
Sektor-
Web-lokacijazeria.co.jp